Andersson B S, Luna M A, McCredie K B
Cancer. 1986 Nov 1;58(9):2146-50. doi: 10.1002/1097-0142(19861101)58:9<2146::aid-cncr2820580931>3.0.co;2-4.
Systemic aspergillosis is encountered with increasing prevalence in immunocompromised patients undergoing chemotherapy. The current communication describes the clinical and postmortem findings in three leukemic patients who developed myocardial infarction secondary to Aspergillus embolization of the coronary arteries. They were all immunosuppressed owing to previous chemotherapy and had been treated for suspected fungal infection with amphotericin B (0.6 mg/kg) for at least 1 week prior to this episode. It is postulated that the infection was spread through the blood since in all three cases the descending branch of the left coronary artery was occluded. Heart involvement resulting from fungal infection should be suspected when chest symptoms of unknown origin occur in this patient population.
在接受化疗的免疫功能低下患者中,系统性曲霉病的发病率日益增加。本报告描述了3例白血病患者的临床和尸检结果,这些患者因冠状动脉曲霉栓塞继发心肌梗死。他们均因先前的化疗而免疫抑制,且在本次发作前至少1周已接受两性霉素B(0.6mg/kg)治疗疑似真菌感染。据推测,感染是通过血液传播的,因为在所有3例病例中左冠状动脉降支均被阻塞。当该患者群体出现不明原因的胸部症状时,应怀疑存在真菌感染导致的心脏受累。